You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Systemic lupus erythematosus (SLE), an autoimmune disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients

Not yet recruiting
  • SLE (Systemic Lupus)
    • (no location specified)
    Oct 1, 2023

    Systemic Lupus Erythematosus (SLE) Trial (Descartes-08)

    Not yet recruiting
    • Systemic Lupus Erythematosus (SLE)
    • (no location specified)
    Sep 8, 2023

    System; Lupus Erythematosus, Cognition Disorder, Autoimmune Trial in Istanbul (Exercise)

    Recruiting
    • System; Lupus Erythematosus
    • +2 more
    • Exercise
    • Istanbul, Turkey
      Biruni University
    Aug 2, 2023

    Systemic Lupus Erythematosus, SLE (Systemic Lupus), Autoimmune Trial in United States (CUG252, Placebo)

    Recruiting
    • Systemic Lupus Erythematosus
    • +2 more
    • Anniston, Alabama
    • +10 more
    May 10, 2023

    3TR Systemic Lupus Erythematosus Study Protocol 2

    Not yet recruiting
    • Systemic Lupus Erythematosus (SLE)
    • Blood sample
    • +4 more
    • (no location specified)
    Feb 17, 2023

    Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

    Recruiting
    • Rheumatoid Arthritis
    • +8 more
    • Moderna mRNA-1273
    • +5 more
    • Los Angeles, California
    • +24 more
    Aug 17, 2022

    Systemic Lupus Erythematosus, Lupus Nephritis Trial in Barcelona (YTB323)

    Recruiting
    • Systemic Lupus Erythematosus
    • Lupus Nephritis
    • Barcelona, Catalunya, Spain
      Novartis Investigative Site
    Mar 22, 2023

    Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in

    Recruiting
    • Lupus Erythematosus, Systemic
    • low dose GR1603 in phase Ⅰb
    • +4 more
    • Beijing, Beijing, China
      Peking union Medical Hosipital
    Aug 22, 2023

    Systemic Lupus Erythematosus Trial (Placebo, Ianalumab)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • (no location specified)
    Nov 15, 2023

    Among Juvenile, Adult, and Late-onset Systemic Lupus

    Not yet recruiting
    • Systemic Lupus Erythematosus (SLE)
    • clinical and serological differences among juvenile, adult, and late-onset systemic lupus erythematosus in a cohort of SLE patients
    • (no location specified)
    Feb 10, 2023

    Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Telitacicept
    • +6 more
    • (no location specified)
    Dec 28, 2022

    Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))

    Recruiting
    • Systemic Lupus Erythematosus (SLE)
    • anti-CD19 CAR NK cells (KN5501)
    • Shanghai, China
      Changhai Hospital
    Aug 25, 2023

    Lupus Erythematosus, Systemic Trial in Berlin (CC-97540, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • Lupus Erythematosus, Systemic
    • Berlin, Germany
      Local Institution - 0025
    May 22, 2023

    Systemic Lupus Erythematosus, Autoimmune Disorder, Vagus Nerve Autonomic Disorder Trial in Barcelona (Parasym 1Hz, Parasym 30Hz,

    Recruiting
    • Systemic Lupus Erythematosus
    • +2 more
    • Parasym 1Hz
    • +2 more
    • Barcelona, Spain
      Hospital Clinic
    Jan 19, 2023

    Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) Trial in Zhongshan (BCMA-CD19 cCAR T cells)

    Recruiting
    • Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
    • BCMA-CD19 cCAR T cells
    • Zhongshan, Guangdong, China
      Zhongshan People's Hospital
    Jul 23, 2022

    Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus Trial in Los Angeles, Atlanta

    Recruiting
    • Systemic Lupus Erythematosus (SLE)
    • +2 more
      • Los Angeles, California
      • +1 more
      Jul 5, 2023

      Lupus Erythematosus, Systemic Trial (Cenerimod, Placebo)

      Not yet recruiting
      • Lupus Erythematosus, Systemic
      • (no location specified)
      Jan 3, 2023

      Systemic Lupus Erythematosus Trial in Syracuse (N-acetylcysteine, Placebo)

      Recruiting
      • Systemic Lupus Erythematosus
      • Syracuse, New York
      • +1 more
      Jun 15, 2022

      Systemic Lupus Erythematosus and Rheumatoid Arthritis

      Recruiting
      • Systemic Lupus Erythematosus
      • +2 more
      • Belimumab in SLE patients / Rituximab in RA patients
      • Monserrato, Cagliari, Italy
        Matteo Piga
      Dec 13, 2022

      SLE Patients Treated With Anifrolumab in Early Access Programs

      Not yet recruiting
      • Systemic Lupus Erythematosus
      • None (Observational study)
      • (no location specified)
      Sep 13, 2023

      Systemic Lupus Erythematosus Trial in Malang (Observe the clinical outcome and inflammatory cytokines levels in patients with

      Completed
      • Systemic Lupus Erythematosus
      • Observe the clinical outcome and inflammatory cytokines levels in patients with systemic lupus erythematosus (SLE) after being supplemented with Cholecalciferol (Vitamin D3) and Curcumin-Piperine.
      • Malang, East Java, Indonesia
        Saiful Anwar General Hospital
      Jun 21, 2022

      Lupus Erythematosus, Systemic Trial in Baytown, Houston (Cenerimod, Placebo)

      Recruiting
      • Lupus Erythematosus, Systemic
      • Baytown, Texas
      • +1 more
      Dec 22, 2022

      Study of Systemic Lupus Erythematosus

      Recruiting
      • Systemic Lupus Erythematosus
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Systemic Lupus Erythematosus, Lupus Nephritis Trial in Los Angeles (IMPT-514)

        Not yet recruiting
        • Systemic Lupus Erythematosus
        • Lupus Nephritis
        • IMPT-514
        • Los Angeles, California
          University of California, Los Angeles (UCLA) Medical Center
        Nov 22, 2023

        CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

        Recruiting
        • CAR-T Cell Therapy
        • GC012F injection
        • Shanghai, Shanghai, China
          Department of Rheumatology, Ren Ji Hospital South Campus, School
        May 5, 2023